{"id":529267,"date":"2021-02-08T15:58:01","date_gmt":"2021-02-08T15:58:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=529267"},"modified":"2021-02-08T15:58:01","modified_gmt":"2021-02-08T15:58:01","slug":"dravet-syndrome-market-drug-insights-and-market-assessment-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dravet-syndrome-market-drug-insights-and-market-assessment-by-delveinsight_529267.html","title":{"rendered":"Dravet Syndrome Market Drug, Insights and Market Assessment by DelveInsight"},"content":{"rendered":"
\"Dravet<\/a><\/div>\n

DelveInsight <\/strong>has launched a new report on “Dravet Syndrome Market<\/a>”<\/strong><\/p>\n

 <\/p>\n

Dravet syndrome<\/strong> (DS) is a rare, catastrophic, lifelong form of epilepsy that begins in the first year of life with frequent and\/or prolonged seizures. It has been defined as a severe form of epilepsy characterized by frequent, prolonged seizures often triggered by high body temperature (hyperthermia), developmental delay, speech impairment, ataxia, hypotonia, sleep disturbances, and other health problems.<\/p>\n

 <\/p>\n

Request for free sample copy- https:\/\/www.delveinsight.com\/sample-request\/dravet-syndrome-market <\/a><\/strong><\/p>\n

 <\/p>\n

The Dravet Syndrome market report<\/strong> provides an edge while developing business strategies, by understanding trends shaping and driving the global<\/strong> Dravet Syndrome<\/strong> market<\/strong><\/p>\n

 <\/p>\n

Dravet Syndrome Treatment<\/strong><\/p>\n

Current treatment options are limited, and the constant care required for someone suffering from Dravet syndrome can severely impact the patient’s and the family’s quality of life. Patients with Dravet syndrome face a 15-20% mortality rate due to SUDEP (Sudden Unexpected Death in Epilepsy), prolonged seizures, seizure-related accidents such as drowning, and infections.<\/p>\n

 <\/p>\n

Dravet Syndrome Market Disease<\/strong><\/p>\n

Three stages are usually identified in association with DS with “Febrile stage” being the first among them, Worsening stage” follows between 1 and 5 years of age and “Stabilization stage” begins by the end of the first decade in which seizures are less frequent<\/p>\n

The Signs and Symptoms of the disease involve seizures, ataxia (balance problems), motor impairment, cognitive impairment, behavioral problems, infections, bone problems, and heart rhythm irregularities.<\/p>\n

 <\/p>\n

Dravet Syndrome Companies<\/strong><\/p>\n